Modulating mammary tumor growth, metastasis and immunosuppression by siRNA-induced MIF reduction in tumor microenvironment (Q38832819)

6 September 2017

title

Modulating mammary tumor growth, metastasis and immunosuppression by siRNA-induced MIF reduction in tumor microenvironment (English)

1 reference

6 September 2017

1 reference

M Zhang

1

1 reference

6 September 2017

L Yan

series ordinal

2

1 reference

6 September 2017

J A Kim

series ordinal

3

1 reference

6 September 2017

publication date

25 September 2015

1 reference

6 September 2017

1 reference

6 September 2017

volume

22

1 reference

6 September 2017

issue

10

1 reference

6 September 2017

page(s)

463-474

1 reference

Emerging targeted agents in metastatic breast cancer

6 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.42

Stromal cells in tumor microenvironment and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.42

Role of macrophages in tumour progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.42

Role of tumor-associated macrophages in tumor progression and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.42

Macrophages define the invasive microenvironment in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.42

Macrophage migration inhibitory factor (MIF): Its potential role in tumor growth and tumor-associated angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.42

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.42

Tumor growth-promoting properties of macrophage migration inhibitory factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.42

Critical role of cysteine residue 81 of macrophage migration inhibitory factor (MIF) in MIF-induced inhibition of p53 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.42

Role of MIF in inflammation and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.42

Chemokine-like functions of MIF in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.42

Dual role of macrophage migration inhibitory factor (MIF) in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.42

Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.42

Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.42

A mouse model of pulmonary metastasis from spontaneous osteosarcoma monitored in vivo by Luciferase imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.42

Immunosuppressive strategies that are mediated by tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.42

The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.42

MIF signal transduction initiated by binding to CD74

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.42

CD74 in antigen presentation, inflammation, and cancers of the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.42

Cell-surface CD74 initiates a signaling cascade leading to cell proliferation and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.42

MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.42

MIF in autoimmunity and novel therapeutic approaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.42

Innate and adaptive immunity in the pathogenesis of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.42

Dynamic interactions of macrophages with T cells during antigen presentation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.42

IL-2: more than a T cell growth factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.42

Macrophage migration inhibitory factor produced by the tumour stroma but not by tumour cells regulates angiogenesis in the B16-F10 melanoma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.42

History of myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.42

Myeloid derived suppressor cells - a new therapeutic target in the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.42

Breakthrough for systemic RNAi

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.42

Tumor-associated macrophages: effectors of angiogenesis and tumor progression.

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26403072

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/CGT.2015.42

1 reference

Dimensions Publication ID

6 September 2017

1042809963

0 references

1 reference